Cargando…
PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure
The effects of PA21, a novel iron-based and non-calcium-based phosphate binder, on hyperphosphatemia and its accompanying bone abnormality in chronic kidney disease-mineral and bone disorder (CKD-MBD) were evaluated. Rats with adenine-induced chronic renal failure (CRF) were prepared by feeding them...
Autores principales: | Yaguchi, Atsushi, Tatemichi, Satoshi, Takeda, Hiroo, Kobayashi, Mamoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509238/ https://www.ncbi.nlm.nih.gov/pubmed/28704404 http://dx.doi.org/10.1371/journal.pone.0180430 |
Ejemplares similares
-
A comparison between the combined effect of calcium carbonate with sucroferric oxyhydroxide and other phosphate binders: an in vitro and in vivo experimental study
por: Yaguchi, Atsushi, et al.
Publicado: (2019) -
Divalent ion metabolism and osteodystrophy in chronic renal failure.
por: Kleeman, C. R., et al.
Publicado: (1967) -
Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines
por: Klaus, G., et al.
Publicado: (2005) -
Bone Canopies in Pediatric Renal Osteodystrophy
por: Pereira, Renata C., et al.
Publicado: (2016) -
Cyst-like Tumors in Renal Osteodystrophy
por: Li Cavoli, Gioacchino, et al.
Publicado: (2021)